Firma Clinical Research   Report issue

For profit Phase 2 Phase 4
Founded: Chicago IL United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Firma Clinical Research (0) Acquired (1)

iobenguane (123i) (1 trial)

Drugs in Phase 2 Trials (1)

Key: Firma Clinical Research (0) Acquired (1)

estradiol (progynon depot) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 2